Literature DB >> 26254821

Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density.

Joseph M McClung1, Timothy J McCord2, Kevin Southerland3, Cameron A Schmidt4, Michael E Padgett2, Terence E Ryan4, Christopher D Kontos5.   

Abstract

OBJECTIVE: The primary preclinical model of peripheral artery disease, which involves acute limb ischemia (ALI), can result in appreciable muscle injury that is attributed to the acuity of the ischemic injury. A less acute model of murine limb ischemia using ameroid constrictors (ACs) has been developed in an attempt to mimic the chronic nature of human disease. However, there is currently little understanding of how genetics influence muscle injury following subacute arterial occlusion in the mouse.
METHODS: We investigated the influence of mouse genetics on skeletal muscle tissue survival, blood flow, and vascular density by subjecting two different mouse strains, C57BL/6 (BL6) and BALB/c, to ALI or subacute limb ischemia using single (1AC) or double (2AC) AC placement on the femoral artery.
RESULTS: Similar to ALI, the 2AC model resulted in significant tissue necrosis and limb perfusion deficits in genetically susceptible BALB/c but not BL6 mice. In the 1AC model, no outward evidence of tissue necrosis was observed, and there were no differences in limb blood flow between BL6 and BALB/c. However, BALB/c mice displayed significantly greater muscle injury, as evidenced by increased inflammation and myofiber atrophy, despite having no differences in CD31(+) and SMA(+) vascular density and area. BALB/c mice also displayed significantly greater centralized myonuclei, indicating increased muscle regeneration.
CONCLUSIONS: The susceptibility of skeletal muscle to ischemia-induced injury is at least partly independent of muscle blood flow and vascular density, consistent with a muscle cell autonomous response that is genetically determined. Further development of preclinical models of peripheral artery disease that more accurately reflect the nature of the human disease may allow more accurate identification of genetic targets for therapeutic intervention.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26254821      PMCID: PMC4744137          DOI: 10.1016/j.jvs.2015.06.139

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  40 in total

1.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.

Authors:  Robert J Lederman; Farrell O Mendelsohn; R David Anderson; Jorge F Saucedo; Alan N Tenaglia; James B Hermiller; William B Hillegass; Krishna Rocha-Singh; Thomas E Moon; M J Whitehouse; Brian H Annex
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

2.  Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells.

Authors:  A Dellavalle; G Maroli; D Covarello; E Azzoni; A Innocenzi; L Perani; S Antonini; R Sambasivan; S Brunelli; S Tajbakhsh; G Cossu
Journal:  Nat Commun       Date:  2011-10-11       Impact factor: 14.919

Review 3.  Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease.

Authors:  E P Brass; W R Hiatt
Journal:  Vasc Med       Date:  2000       Impact factor: 3.239

4.  An improved ameroid constrictor. Preliminary communication.

Authors:  J J Bredée
Journal:  J Surg Res       Date:  1969-02       Impact factor: 2.192

Review 5.  Satellite cells, the engines of muscle repair.

Authors:  Yu Xin Wang; Michael A Rudnicki
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-21       Impact factor: 94.444

6.  The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia.

Authors:  Gale L Tang; David S Chang; Rajabrata Sarkar; Rong Wang; Louis M Messina
Journal:  J Vasc Surg       Date:  2005-02       Impact factor: 4.268

7.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Authors:  A Rivard; M Silver; D Chen; M Kearney; M Magner; B Annex; K Peters; J M Isner
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Authors:  Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

9.  Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo.

Authors:  Vincent van Weel; Martine M L Deckers; Jos M Grimbergen; Kees J M van Leuven; JanWillem H P Lardenoye; Reinier O Schlingemann; Geerten P van Nieuw Amerongen; J Hajo van Bockel; Victor W M van Hinsbergh; Paul H A Quax
Journal:  Circ Res       Date:  2004-05-20       Impact factor: 17.367

10.  Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

Authors:  Arianna Dellavalle; Maurilio Sampaolesi; Rossana Tonlorenzi; Enrico Tagliafico; Benedetto Sacchetti; Laura Perani; Anna Innocenzi; Beatriz G Galvez; Graziella Messina; Roberta Morosetti; Sheng Li; Marzia Belicchi; Giuseppe Peretti; Jeffrey S Chamberlain; Woodring E Wright; Yvan Torrente; Stefano Ferrari; Paolo Bianco; Giulio Cossu
Journal:  Nat Cell Biol       Date:  2007-02-11       Impact factor: 28.824

View more
  19 in total

1.  BAG3 (Bcl-2-Associated Athanogene-3) Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy.

Authors:  Joseph M McClung; Timothy J McCord; Terence E Ryan; Cameron A Schmidt; Tom D Green; Kevin W Southerland; Jessica L Reinardy; Sarah B Mueller; Talaignair N Venkatraman; Christopher D Lascola; Sehoon Keum; Douglas A Marchuk; Espen E Spangenburg; Ayotunde Dokun; Brian H Annex; Christopher D Kontos
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

2.  N-acetylcysteine differentially regulates the populations of bone marrow and circulating endothelial progenitor cells in mice with limb ischemia.

Authors:  Yuqi Cui; Lingjuan Liu; Yuan Xiao; Xin Li; Jia Zhang; Xiaoyun Xie; Jie Tian; Chandan K Sen; Xiaoming He; Hong Hao; Zhenguo Liu
Journal:  Eur J Pharmacol       Date:  2020-05-31       Impact factor: 4.432

3.  Methods for Acute and Subacute Murine Hindlimb Ischemia.

Authors:  Michael E Padgett; Timothy J McCord; Joseph M McClung; Christopher D Kontos
Journal:  J Vis Exp       Date:  2016-06-21       Impact factor: 1.355

4.  Diminished force production and mitochondrial respiratory deficits are strain-dependent myopathies of subacute limb ischemia.

Authors:  Cameron A Schmidt; Terence E Ryan; Chien-Te Lin; Melissa M R Inigo; Tom D Green; Jeffrey J Brault; Espen E Spangenburg; Joseph M McClung
Journal:  J Vasc Surg       Date:  2016-12-23       Impact factor: 4.268

5.  E-Selectin/AAV2/2 Gene Therapy Alters Angiogenesis and Inflammatory Gene Profiles in Mouse Gangrene Model.

Authors:  Antoine J Ribieras; Yulexi Y Ortiz; Yan Li; Carlos T Huerta; Nga Le; Hongwei Shao; Roberto I Vazquez-Padron; Zhao-Jun Liu; Omaida C Velazquez
Journal:  Front Cardiovasc Med       Date:  2022-06-16

6.  Strain-Dependent Variation in Acute Ischemic Muscle Injury.

Authors:  Cameron A Schmidt; Adam J Amorese; Terence E Ryan; Emma J Goldberg; Michael D Tarpey; Thomas D Green; Reema R Karnekar; Dean J Yamaguchi; Espen E Spangenburg; Joseph M McClung
Journal:  Am J Pathol       Date:  2018-02-16       Impact factor: 4.307

7.  Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.

Authors:  Terence E Ryan; Dean J Yamaguchi; Cameron A Schmidt; Tonya N Zeczycki; Saame Raza Shaikh; Patricia Brophy; Thomas D Green; Michael D Tarpey; Reema Karnekar; Emma J Goldberg; Genevieve C Sparagna; Maria J Torres; Brian H Annex; P Darrell Neufer; Espen E Spangenburg; Joseph M McClung
Journal:  JCI Insight       Date:  2018-11-02

8.  Gene Expression Signature in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Jonathan D Newman; MacIntosh G Cornwell; Hua Zhou; Caron Rockman; Adriana Heguy; Yajaira Suarez; Henry S Cheng; Mark W Feinberg; Judith S Hochman; Kelly V Ruggles; Jeffrey S Berger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-03-04       Impact factor: 8.311

9.  Strain-specific differences in muscle Ca2+ transport and mitochondrial electron transport chain proteins between FVB/N and C57BL/6J mice.

Authors:  Sushant Singh; Muthu Periasamy; Naresh C Bal
Journal:  J Exp Biol       Date:  2021-01-15       Impact factor: 3.312

10.  Targeted Expression of Catalase to Mitochondria Protects Against Ischemic Myopathy in High-Fat Diet-Fed Mice.

Authors:  Terence E Ryan; Cameron A Schmidt; Thomas D Green; Espen E Spangenburg; P Darrell Neufer; Joseph M McClung
Journal:  Diabetes       Date:  2016-06-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.